Vantage Financial Partners Ltd., Inc. Bristol Myers Squibb CO Transaction History

Vantage Financial Partners Ltd., Inc.

$374 Million
Q1 2024

A detailed history of Vantage Financial Partners Ltd., Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Vantage Financial Partners Ltd., Inc. holds 10,425 shares of BMY stock, worth $413,455. This represents 0.15% of its overall portfolio holdings.

Number of Shares

10,425

Previous 10,275 1.46%

Holding current value

$413,455

Previous $527,000 7.21%

% of portfolio

0.15%

Previous 0.16%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $7,196 - $8,160	150 Added 1.46%	10,425 $565,000
Q4 2023 Feb 13, 2024	SELL	$48.48 - $57.85 $116,351 - $138,840	-2,400 Reduced 18.93%	10,275 $527,000
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $41,970 - $46,929	-725 Reduced 5.41%	12,675 $735,000
Q2 2023 Aug 08, 2023	SELL	$63.71 - $70.74 $12,742 - $14,147	-200 Reduced 1.47%	13,400 $856,000
Q1 2023 May 04, 2023	SELL	$65.71 - $74.53 $77,209 - $87,572	-1,175 Reduced 7.95%	13,600 $942,000

Q4 2022 Feb 07, 2023	SELL	$68.48 - $81.09 $20,544 - $24,327	-300 Reduced 1.99%	14,775 $1.06 Million
Q3 2022 Nov 09, 2022	SELL	$0.13 - $76.84 $224 - $132,549	-1,725 Reduced 10.27%	15,075 $1.07 Million
Q1 2022 May 02, 2022	SELL	$61.48 - $73.72 $24,592 - $29,488	-400 Reduced 2.33%	16,800 $1.23 Million
Q4 2021 Jan 27, 2022	BUY	$53.63 - $62.52 $32,178 - $37,512	600 Added 3.61%	17,200 $1.07 Million
Q3 2021 Nov 05, 2021	SELL	$59.17 - $69.31 $106,506 - $124,758	-1,800 Reduced 9.78%	16,600 $982,000
Q2 2021 Aug 11, 2021	BUY	$61.91 - $67.42 $30,955 - $33,710	500 Added 2.79%	18,400 $1.23 Million
Q4 2020 Feb 05, 2021	BUY	$57.74 - $65.43 $51,966 - $58,887	900 Added 5.29%	17,900 $1.11 Million
Q3 2020 Nov 09, 2020	BUY	$57.43 - $63.64 $28,715 - $31,820	500 Added 3.03%	17,000 $1.02 Million
Q2 2020 Aug 07, 2020	BUY	$54.82 - $64.09 $21,928 - $25,636	400 Added 2.48%	16,500 $970,000
Q1 2020 May 12, 2020	BUY	$46.4 - $67.43 $162,400 - $236,005	3,500 Added 27.78%	16,100 $897,000
Q4 2019 Jan 27, 2020	BUY	$49.21 - $64.19 $152,551 - $198,989	3,100 Added 32.63%	12,600 $809,000
Q3 2019 Nov 07, 2019	BUY	$42.77 - $50.71 $145,418 - $172,414	3,400 Added 55.74%	9,500 $481,000
Q2 2019 Aug 08, 2019	BUY	$44.62 - $49.34 $17,848 - $19,736	400 Added 7.02%	6,100 $0
Q1 2019 May 09, 2019	SELL	$45.12 - $53.8 $40,608 - $48,420	-900 Reduced 13.64%	5,700 $0
Q4 2018 Feb 12, 2019	BUY	$48.76 - $63.23 $24,380 - $31,615	500 Added 8.2%	6,600 $343,000
Q1 2018 May 07, 2018	BUY	$59.92 - $68.98 $17,976 - $20,694	300 Added 5.17%	6,100 $386,000
Q4 2017 Feb 09, 2018	BUY	$59.94 - $65.35 $5,994 - $6,534	100 Added 1.75%	5,800 $358,000
Q3 2017 Nov 02, 2017	BUY	$55.23 - $63.74 $314,811 - $363,318	5,700	5,700 $362,000

Others Institutions Holding BMY

# of Institutions

2,553

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $84.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vantage Financial Partners Ltd., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vantage Financial Partners Ltd., Inc. with notifications on news.

Account

Vantage Financial Partners Ltd., Inc. Bristol Myers Squibb CO Transaction History